Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126672891 | 12667289 | 1 | I | 20160809 | 0 | 20160818 | 20160818 | DIR | 3.36 | YR | F | N | 10.50000 | KG | 20160812 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126672891 | 12667289 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | 36 | MG | ||||||||||
| 126672891 | 12667289 | 2 | SS | ONCASPAR | PEGASPARGASE | 1 | 0 | 1325 | IU | ||||||||||
| 126672891 | 12667289 | 3 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 0 | 2.4 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126672891 | 12667289 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126672891 | 12667289 | Agitation | |
| 126672891 | 12667289 | Alanine aminotransferase increased | |
| 126672891 | 12667289 | Aspartate aminotransferase increased | |
| 126672891 | 12667289 | Blood blister | |
| 126672891 | 12667289 | Blood glucose decreased | |
| 126672891 | 12667289 | Candida infection | |
| 126672891 | 12667289 | Cardiac arrest | |
| 126672891 | 12667289 | Erythema | |
| 126672891 | 12667289 | Hypotension | |
| 126672891 | 12667289 | Metabolic acidosis | |
| 126672891 | 12667289 | Platelet count decreased | |
| 126672891 | 12667289 | Pleural effusion | |
| 126672891 | 12667289 | Pseudomonas test positive | |
| 126672891 | 12667289 | Pyrexia | |
| 126672891 | 12667289 | Rash | |
| 126672891 | 12667289 | Respiratory distress | |
| 126672891 | 12667289 | Swelling | |
| 126672891 | 12667289 | Tachycardia | |
| 126672891 | 12667289 | Ulcer | |
| 126672891 | 12667289 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126672891 | 12667289 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126672891 | 12667289 | 1 | 20160809 | 0 | ||
| 126672891 | 12667289 | 2 | 20160724 | 0 | ||
| 126672891 | 12667289 | 3 | 20160804 | 0 |